Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06960967 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Chestnuts on Postprandial Glycaemic Response

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting Completion date: Apr 2026 to Apr 30, 2026 · Site details revisedv3 Show 2 more changesShow less
    • Completion date: Apr 2026 to Apr 30, 2026
    • Site details revised
  2. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Primary completion date changed from estimate of Dec 2025 to Aug 18, 2025 · Completion date: Dec 2025 to Apr 2026 · 1 morev2 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date changed from estimate of Dec 2025 to Aug 18, 2025
    • Completion date: Dec 2025 to Apr 2026
    • Start date changed from estimate of May 12, 2025 to Jun 6, 2025
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Nut consumption is known to improve health outcomes, such as reducing the risk of chronic diseases like diabetes, cognitive impairment, and cardiovascular diseases. While most research has focused on walnuts and almonds, there is limited information on the health benefits of chestnuts. Chestnuts are unique among tree nuts due to their high starch and fibre content, along with vitamins E and C, minerals (potassium, phosphorus, magnesium), and polyphenols. Evidence from in vitro and animal studies suggests that chestnuts may positively affect health by regulating the gut microbiome, lowering the glycaemic index, and providing antioxidant benefits. The food industry is also exploring new uses for chestnuts, particularly in gluten-free products, due to their nutritional benefits and good taste. Nonetheless, no research has investigated the health effects of chestnuts in humans. By addressing this gap in the literature, the study may lead to the development of new dietary strategies for improved health outcomes.
Trial Details
NCT Number NCT06960967
Lead Sponsor Monash University
Conditions Postprandial Glycemia, Insulin Resistance
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov